#biotech

Recent public posts

Sign in to join the #biotech conversation

Sign in / Join free

13 Apr 2026

Europe’s pharmaceutical sector faces pressure as U.S. trade policies under Donald Trump and China’s biotech rise reshape global competition. Declining R&D share and rising tariffs are pushing companies to shift investments, intensifying concerns over Europe’s future role in the global drug industry. #Europe #Pharma #China #USA #TradeWar #Biotech #GlobalEconomy

Post by Jacob Smith

3 likes3 comments#europe #globaleconomy #china #pharma #biotech

30 Mar 2026

Novartis Deal Novartis is planning a $2 billion acquisition of biotech firm Excellergy, betting big on next-generation allergy treatments. The move underscores growing competition and innovation in the global pharmaceutical sector. #Novartis #Biotech #Pharma #Healthcare #Investment #Innovation

Post by Jacob Smith

5 likes5 comments#biotech #novartis #investment #innovation #healthcare

26 Mar 2026

Merck Acquisition 💊 Pharma giant Merck is acquiring Terns Pharmaceuticals for $6.7 billion, signaling strong expansion in biotech innovation and drug development capabilities. #Pharma #Merck #Biotech #Healthcare #BusinessDeal

Post by Jacob Smith

5 likes5 comments#biotech #businessdeal #merck #healthcare #pharma

25 Mar 2026

Biotech firm Abivax is planning to raise funds after releasing key trial data, signaling strong confidence in its pipeline. The company says it is not rushing into a sale, keeping options open amid growing investor interest. #Biotech #Abivax #Healthcare #Investing #Pharma

Post by Jacob Smith

8 likes7 comments#biotech #investing #abivax #healthcare #pharma